GRDN
Guardian Pharmacy Services, Inc.
NYSE: GRDN · HEALTHCARE · MEDICAL CARE FACILITIES
$37.10
-1.25% today
Updated 2026-04-30
Market cap
$2.42B
P/E ratio
48.19
P/S ratio
1.67x
EPS (TTM)
$0.78
Dividend yield
—
52W range
$19 – $41
Volume
0.5M
Guardian Pharmacy Services, Inc. (GRDN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $600.37M | $698.29M | $735.96M | $792.07M | $908.91M | $1.05B | $1.23B | $1.45B |
| Revenue growth (YoY) | — | +16.3% | +5.4% | +7.6% | +14.8% | +15.1% | +17.4% | +17.9% |
| Cost of revenue | $477.33M | $554.83M | $588.96M | $630.81M | $723.04M | $837.88M | $984.04M | $1.17B |
| Gross profit | $123.03M | $143.46M | $147.00M | $161.26M | $185.87M | $208.31M | $244.37M | $282.04M |
| Gross margin | 20.5% | 20.5% | 20.0% | 20.4% | 20.4% | 19.9% | 19.9% | 19.5% |
| R&D | — | — | — | — | — | — | — | — |
| SG&A | — | — | $102.54M | $13.03M | $3.38M | $167.36M | $299.35M | $220.02M |
| Operating income | $25.93M | $34.10M | $32.06M | $30.15M | $51.99M | $40.95M | $-62.92M | $88.91M |
| Operating margin | 4.3% | 4.9% | 4.4% | 3.8% | 5.7% | 3.9% | -5.1% | 6.1% |
| EBITDA | $38.30M | $49.47M | $49.07M | $46.49M | $68.15M | $58.81M | $-43.43M | $111.25M |
| EBITDA margin | 6.4% | 7.1% | 6.7% | 5.9% | 7.5% | 5.6% | -3.5% | 7.7% |
| EBIT | $25.17M | $33.62M | $31.82M | $29.96M | $51.59M | $40.58M | $-63.20M | $88.91M |
| Interest expense | $1.90M | $2.25M | $2.16M | $1.64M | $1.93M | $2.86M | $3.28M | $665000.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $14.68M | $21.75M | $19.94M | $16.31M | $35.42M | $23.90M | $-87.29M | $49.22M |
| Net income growth (YoY) | — | +48.1% | -8.3% | -18.2% | +117.1% | -32.5% | -465.2% | +156.4% |
| Profit margin | 2.4% | 3.1% | 2.7% | 2.1% | 3.9% | 2.3% | -7.1% | 3.4% |